Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials

Glucagon-like Peptide 1 Receptor Agonists (GLP1-RA) has been associated with a reduction of major cardiovascular events (MACE) and mortality on the basis of the results of cardiovascular outcome trials (CVOT). Several meta-analyses on this issue have been recently published; however, they were all r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2020-06, Vol.30 (7), p.1106-1114
Hauptverfasser:	Nreu, Besmir, Dicembrini, Ilaria, Tinti, Federico, Sesti, Giorgio, Mannucci, Edoardo, Monami, Matteo
Format:	Artikel
Sprache:	eng
Schlagworte:	All-cause mortality Atrial fibrillation Glucagon-like peptide-1 receptor agonists Heart failure Major amputations Major cardiovascular events Meta-analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!